Top Innovative Companies
Top from left: The Ipsen Pharma GmbH management team welcomes the renewed challenge for the 2016 TOP 100 award. Joachim Koops and medical & regulatory director Dr. Martin Gerwe accept the 2015 Top 100 award. Joachim Koops, managing director for Ipsen Pharma GmbH since 2003. Ettlingen-based Ipsen Pharma GmbH distribute their products in Germany, Austria and Switzerland.
Germany
Come together:
Ipsen Pharma GmbH envisions a mutual approach within the health sector For Germany’s Ipsen Pharma GmbH, innovation means integration: “Our vision of the future is a health system for which everybody involved is pulling together,” states general manager Joachim Koops. An inspirational firm culture and reaching out to the patient for firsthand feedback, form the innovative company policy which won Ipsen Pharma the German TOP 100 award in 2015. TEXT: CORNELIA BRELOWSKI I PHOTOS: IPSEN PHARMA GMBH
“Small steps can inspire meaningful change” is the company’s motto, which for the staff means annual inspirational treats ranging from mountain hikes to keynote speeches by trend analysts. But “small steps” also means finding alternatives to cost-intensive new drugs, such as implementing a new information strategy or varying dosage forms. “Improving the well-being of patients doesn’t necessarily mean launching a new product,” says medical director Dr. Martin Gerwe. A successful example is Ipsen Pharma’s involvement in a recent study on movement disorder for a clinic in Zwickau. Based on the outcome of the study, a new training concept was developed by a team of experts, helping doctors to apply 90 | Issue 39 | June 2016
an existing neurological drug in a more targeted and therefore more effective way. The new concept quickly won international recognition. Ettlingen-based Ipsen Pharma GmbH, subsidiary to the international Ipsen group, has steadily grown into a mid-sized firm over the past 35 years. With six core products on the market, the company has lately started distributing to clients in Austria and Switzerland as well as covering the German market. During challenging times within the pharmaceutical sector, the “David amongst the Goliaths” have found their own remedy for survival and growth. Apart from embracing challenge and innovation, the firm’s success is
largely due to their close-to-the-patient policy and inspired company culture. By receiving the TOP 100 award in the field of “innovative climate”, Ipsen Pharma GmbH has officially become part of the innovative elite of Germany’s small firm sector. The company wants to keep walking the path of innovation fueled by curiosity, always open to change, together with patients and prescribers, co-workers and business partners. And the next challenges are lying ahead – Ipsen has re-submitted an application for the TOP 100 award in 2016 and new launches are expected in the field of oncology. As Joachim Koops formulates: “We’d like to share our dream for the future, to tackle and see it through together: An integrative health system in which everyone enjoys togetherness as a rule – not as an exception - for the patients’ benefit.” www.ipsen-pharma.de